InvestorsHub Logo
Followers 34
Posts 3017
Boards Moderated 0
Alias Born 02/27/2016

Re: None

Thursday, 04/09/2020 1:05:38 PM

Thursday, April 09, 2020 1:05:38 PM

Post# of 464899
Our low float is going to help us rocket. It's amazing that we have NO debt and less than 60 million shares outstanding. As another poster recently stated. He could have diluted the crap out of us, done a secondary, partnered for indications but instead he gets the blank check preferreds to protect us, dilutes minimally and gets us multiple ways of funding.

That speaks confidence. If he went any other route we would be at a much higher sp. He could have been rich, our company could have had stacks of cash with BP backup but no he decided to forgo all of that and fly under the radar.

Could have gone with the corrupt FDA but went with trial friendly Australia and Spain. Could have rushed into trials 5 years ago when the FDA told them they could but instead they wanted to really research their drug. Illumina, Ariana, biomarker exploration, dna and rna analysis, etc.

Knowing all these things but he did what he did. Not alone but with a distinguished team of veteran experts in their field. Why why why?

Now we will find out. Will it be the first in a long list of promising indications? Will it blow the amyloid hypothesis to hell once and for all? Will we be the next BP??

Will we be a true paradigm shifting giant? We will know soon enough.

Soon is actually soon this time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News